CLDN1 and colonic neoplasm: Specifically, the increased expression of Claudin-1 in colon cancer correlated with metastasis and poor prognosis40–42, and with poor outcome in high grade invasive ductal carcinoma of the breast where it correlated with the molecular subtype43.